Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jtho.2024.11.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Role of neoadjuvant chemo-radiotherapy for resectable and borderline resectable pancreatic adenocarcinoma- A systematic review and meta-analysis.
Int J Radiat Oncol Biol Phys
March 2025
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan; Department of Oncology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address:
Background: Randomized trials and meta-analyses have indicated longer survival with neoadjuvant than with adjuvant therapy in patients with resectable or borderline resectable (R/BR) pancreatic adenocarcinoma. Despite the efficacy of chemotherapy, the role of radiotherapy as an adjuvant or neoadjuvant treatment for patients with R/BR pancreatic adenocarcinoma remains unclear. In this systematic review and meta-analysis, we compared the benefits of additional chemoradiotherapy (CRT) to neoadjuvant chemotherapy (NAC) with NAC alone for R/BR pancreatic adenocarcinoma.
View Article and Find Full Text PDF[A Case of Pancreatic Carcinoma and Short Bowel Syndrome with Long-Term Survival].
Gan To Kagaku Ryoho
February 2025
Dept. of Surgery, Kinan Hospital.
A 75-year-old woman was admitted to our hospital with a complaint of jaundice and elevated liver enzyme levels. She was diagnosed with pancreatic head carcinoma after examination. She had undergone massive resection of the small intestine due to thrombosis of the superior mesenteric artery at 48 years of age, and the remaining ileum was approximately 70 cm in length.
View Article and Find Full Text PDF[A Case of Successful Hepatic Resection of Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab for Recurrent Liver and Lung Metastases].
Gan To Kagaku Ryoho
February 2025
Dept. of General Surgery, Graduate School of Medicine, Chiba University.
Drug therapy for hepatocellular carcinoma has made remarkable progress in recent years, and surgical resection of tumors that respond well to drug therapy has been performed in some cases. We report a case of hepatocellular carcinoma with hepatopulmonary metastases that was successfully treated with atezolizumab plus bevacizumab and surgically resected. The patient was a 56-year-old man who underwent a posterior segmentectomy and was diagnosed with hepatocellular carcinoma.
View Article and Find Full Text PDF[The Short-Term Outcome of Robotic Liver Resection-A Single Institutional Experience].
Gan To Kagaku Ryoho
February 2025
Dept. of Surgery, Kansai Rosai Hospital.
Introduction: Robotic liver resection(RLR)has been covered by insurance since 2022. We report our short-term outcomes of RLR performed in Kansai Rosai Hospital.
Patients And Method: Between May 2022 and November 2023, 35 patients underwent RLR.
[Short-Term Outcomes of Robot-Assisted Laparoscopic Surgery for Rectal Cancer in Our Department].
Gan To Kagaku Ryoho
February 2025
Dept. of Surgery, Tokyo Women's Medical University Adachi Medical Center.
We investigated the short-term outcomes of robot-assisted surgery for rectal cancer in our department. Among 98 cases of colorectal cancer who underwent robot-assisted surgery between October 2019 and December 2023, 91 cases of rectal cancer surgery using the da Vinci X surgical system® were included, and clinicopathological and surgical outcomes were examined. The patients included 58 males and 33 females, with a median age of 71 years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!